Teva Settles With BMS, Merck Over HIV Drug Generic Plans
Teva Pharmaceuticals Industries Ltd. on Wednesday agreed to a settlement with Bristol-Myers Squibb Co. and Merck Sharp & Dohme Corp., ending claims in New York federal court that its planned generic...To view the full article, register now.
Already a subscriber? Click here to view full article